Dr. Martens plc (LON:DOCS - Get Free Report)'s stock price reached a new 52-week low during trading on Thursday . The company traded as low as GBX 47.52 ($0.61) and last traded at GBX 49.56 ($0.63), with a volume of 3938522 shares traded. The stock had previously closed at GBX 53 ($0.68).
Dr. Martens Stock Performance
The firm has a market capitalization of £475.87 million, a price-to-earnings ratio of 6.95, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The firm's 50-day moving average price is GBX 61.20 and its two-hundred day moving average price is GBX 62.73. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85.
Dr. Martens Cuts Dividend
The business also recently disclosed a dividend, which will be paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th will be paid a GBX 0.85 ($0.01) dividend. The ex-dividend date is Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens's dividend payout ratio is currently 42.53%.
Insider Transactions at Dr. Martens
In other news, insider Giles Wilson acquired 32,640 shares of the firm's stock in a transaction on Tuesday, March 25th. The shares were purchased at an average cost of GBX 54 ($0.69) per share, with a total value of £17,625.60 ($22,521.85). In the last ninety days, insiders purchased 33,338 shares of company stock valued at $1,807,831. Corporate insiders own 4.36% of the company's stock.
About Dr. Martens
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Featured Stories
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
